Hetero
Shyam Kumar Midigudla has a strong work background in the pharmaceutical industry. Shyam Kumar currently holds the position of Cluster Head at Hetero, starting in April 2023. Prior to this, Shyam worked as the General Manager at Hetero Drugs Ltd from April 2020 until August 2023. Before that, they served as the Country Manager at Seven Pharma Chile SpA from March 2015 to August 2023. Shyam also gained experience as the Global Sales Manager at HLL Lifecare Limited from April 2013 to February 2015, the Gerente General at Reddy Industries Limited from June 2011 to March 2013, and the International Business Executive at BioGenex Laboratories Ltd from January 2009 to May 2011.
Shyam Kumar Midigudla completed their Senior Management Program from the Indian Institute of Management Nagpur in the field of Business, Management, Marketing, and Related Support Services from 2021 to 2022. Prior to that, they pursued an MBA degree specializing in Marketing & HR from the Indian Institute of Planning and Management from 2007 to 2009. Shyam started their higher education journey by obtaining their Bachelor's degree in Chemistry, Biochemistry, and Biotechnology from Osmania University between 2004 and 2007.
This person is not in any teams
This person is not in any offices
Hetero
4 followers
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Backed by 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics. The company is globally recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, approved by stringent global regulatory authorities. Our portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc. Hetero has a strong global presence in over 145+ countries and focusses on making affordable medicines accessible to patients worldwide.